CRBU — Caribou Biosciences Share News
0.000.00%
- $57.12m
- -$55.19m
- $11.16m
Brief: Caribou Biosciences Reports Second Quarter 2022 Financial Results
U.S. STOCKS ON THE MOVE-Stitch Fix, Illumina, U.S. retail stocks, banks
U.S. STOCKS ON THE MOVE-Cogent Biosciences, Roblox, U.S. banks, retail stocks
U.S. STOCKS ON THE MOVE-Netflix, Rent the Runway, Roblox, eBay
Caribou Bio slips as cancer therapy data disappoints
Brief: Caribou Biosciences Says Positive Additional Data From CB-010 Allogeneic CAR-T Cell Therapy Phase 1 Antler Trial
Caribou Biosciences jumps on promising data from cancer drug study
U.S. RESEARCH ROUNDUP- Applied Blockchain, Cheniere Energy, Roblox
U.S. RESEARCH ROUNDUP- Cepton, Helios Technologies, Marinus Pharmaceuticals
Brief: Caribou Biosciences Reports Fourth Quarter Loss Per Share Of $0.31
U.S. RESEARCH ROUNDUP-Caribou Biosciences, Immunogen, Supernus Pharmaceuticals
Brief: Caribou Biosciences Reports Qtrly Loss Per Share $0.46
Brief: Caribou Biosciences Inc - On September 24, Increased The Size Of The Board From Five To Six Directors
Brief: Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng To Its Board Of Directors
Brief: Caribou Biosciences Provides Business Update
Brief: Caribou Biosciences Appoints Nancy Whiting To Its Board
Brief: Caribou Biosciences Shares Open 10.3% Above IPO Price On Nasdaq Debut
NASDAQ RESUMED AT 11:47 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM